BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23247655)

  • 1. Bleeding complications in patients with hematologic malignancies.
    Franchini M; Frattini F; Crestani S; Bonfanti C
    Semin Thromb Hemost; 2013 Feb; 39(1):94-100. PubMed ID: 23247655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemorrhagic complications in pediatric hematologic malignancies.
    Athale UH; Chan AK
    Semin Thromb Hemost; 2007 Jun; 33(4):408-15. PubMed ID: 17525898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Thrombohemorrhagic Syndromes (THS) in hematologic malignancies.
    Falanga A; Rickles FR
    Hematology Am Soc Hematol Educ Program; 2007; ():165-71. PubMed ID: 18024625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboembolic and bleeding complications in acute leukemia.
    Kwaan HC; Huyck T
    Expert Rev Hematol; 2010 Dec; 3(6):719-30. PubMed ID: 21091148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematologic malignancies and thrombosis.
    Elice F; Rodeghiero F
    Thromb Res; 2012 Mar; 129(3):360-6. PubMed ID: 22197450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated intravascular coagulation in hematologic malignancies.
    Franchini M; Di Minno MN; Coppola A
    Semin Thromb Hemost; 2010 Jun; 36(4):388-403. PubMed ID: 20614391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercoagulability and tissue factor gene upregulation in hematologic malignancies.
    Falanga A; Barbui T; Rickles FR
    Semin Thromb Hemost; 2008 Mar; 34(2):204-10. PubMed ID: 18645927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects on hemostatic function of drugs used in hematologic malignancies.
    Zakarija A; Kwaan HC
    Semin Thromb Hemost; 2007 Jun; 33(4):355-64. PubMed ID: 17525893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of bleeding complications of hematologic malignancies.
    Green D
    Semin Thromb Hemost; 2007 Jun; 33(4):427-34. PubMed ID: 17525900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and pathogenesis of thrombosis in hematologic malignancies.
    Kwaan HC; Vicuna B
    Semin Thromb Hemost; 2007 Jun; 33(4):303-12. PubMed ID: 17525887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation abnormalities in malignancy: a review.
    Bick RL
    Semin Thromb Hemost; 1992; 18(4):353-72. PubMed ID: 1470924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding and thrombosis in acute leukemia: what does the future of therapy look like?
    Rickles FR; Falanga A; Montesinos P; Sanz MA; Brenner B; Barbui T
    Thromb Res; 2007; 120 Suppl 2():S99-106. PubMed ID: 18023721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravascular clotting activation and bleeding in patients with hematologic malignancies.
    Tallman MS; Kwaan HC
    Rev Clin Exp Hematol; 2004 Jun; 8(1):E1. PubMed ID: 16029967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of thrombosis in patients with hematologic malignancies.
    Piccioli A; Vianello F; Prandoni P
    Curr Hematol Rep; 2002 Sep; 1(1):79-83. PubMed ID: 12901128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of thromboembolism in hematologic malignancies.
    Chong BH; Lee SH
    Semin Thromb Hemost; 2007 Jun; 33(4):435-48. PubMed ID: 17525901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboembolic complications in pediatric hematologic malignancies.
    Athale UH; Chan AK
    Semin Thromb Hemost; 2007 Jun; 33(4):416-26. PubMed ID: 17525899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study.
    Cortelezzi A; Moia M; Falanga A; Pogliani EM; Agnelli G; Bonizzoni E; Gussoni G; Barbui T; Mannucci PM;
    Br J Haematol; 2005 Jun; 129(6):811-7. PubMed ID: 15953009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances and challenges in infectious diseases supportive care of patients with hematologic malignancies, hematopoietic stem cell transplantation, and severe aplastic anemia.
    Walsh TJ
    Semin Hematol; 2009 Jul; 46(3):191-7. PubMed ID: 19549573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial Fibrillation in Hematologic Malignancies, Especially After Autologous Hematopoietic Stem Cell Transplantation: Review of Risk Factors, Current Management, and Future Directions.
    Mathur P; Paydak H; Thanendrarajan S; van Rhee F
    Clin Lymphoma Myeloma Leuk; 2016 Feb; 16(2):70-5. PubMed ID: 26776085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.